Dr. Matthew Walker and Dr. Andrew Huberman discuss how marijuana affects sleep.
Dr. Matthew Walker is a professor of neuroscience and psychology at the University of California, Berkeley and is the author of the New York Times bestseller, “Why We Sleep”. Dr. Andrew Huberman is a neuroscientist and tenured professor in the Department of Neurobiology at the Stanford University School of Medicine.
#HubermanLab #Sleep #MattWalker
Full interview with Dr. Matt Walker: https://youtu.be/gbQFSMayJxk
Please note that The Huberman Lab Podcast is distinct from Dr. Huberman’s teaching and research roles at Stanford University School of Medicine. The information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Huberman Lab Podcast, its employees, guests and affiliates assume no liability for the application of the information discussed.
With 1,000mg of premium hemp oil in every ounce, Cannaphyll’s hemp-infused topicals are the most potent on the market, and are crafted with USA-grown, organic ingredients.
A new Canadian study shows the risk of heart attacks nearly doubles among adults under the age of 45 who use cannabis more than four times a month. Researchers say the findings don’t prove that cannabis causes heart attacks, but the study serves as a reminder that it is not a harmless substance.
#cannabis #weed #hearthealth
Watch The National live on YouTube Sunday-Friday at 9 p.m. ET
Subscribe to The National:
https://www.youtube.com/user/CBCTheNational?sub_confirmation=1
Connect with The National online:
Facebook | https://www.facebook.com/thenational
Twitter | https://twitter.com/CBCTheNational
Instagram | https://www.instagram.com/cbcthenational
More from CBC News | https://www.cbc.ca/news
The National is CBC’s flagship nightly news program, featuring the day’s top stories with in-depth and original journalism, with hosts Adrienne Arsenault and Andrew Chang in Toronto, Ian Hanomansing in Vancouver and the CBC’s chief political correspondent, Rosemary Barton in Ottawa.
Cannabis is rapidly becoming one of the most consumed drugs in Canada. Many report using the drug as a coping mechanism for stress and anxiety. How exactly do our stress responses change in the presence of cannabis? Does cannabis actually relieve stress? This video considers the stress relieving effects of cannabis as it interacts with our body’s stress reaction system: the hypothalamic pituitary adrenal axis (HPA-axis). Followed by the potential of cannabis for treating chronic and acute stress related disorders. As research continues on the full uses of cannabis, this video serves as an overview of the research published thus far. If you are using cannabis to cope with stress, please do so safely by monitoring your usage, and reaching out to a registered healthcare professional for more guidance on coping with stress.
This video was made by McMaster students Armaan Sekhon, Kriti Manuja, Krishna Patel & Sharleen Maduranayagam in collaboration with the McMaster Demystifying Medicine Program.
Copyright McMaster University 2021
References:
Canadian Centre on Substance Use and Addiction. (n.d.). Cannabis (Canadian Drug Summary) [Topic Summary]. Retrieved October 9, 2020, from https://www.ccsa.ca/cannabis-canadian-drug-summary
Childs, E., Lutz, J. A., & de Wit, H. (2017). Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug and Alcohol Dependence, 177, 136–144. https://doi.org/10.1016/j.drugalcdep.2017.03.030
Cuttler, C., Spradlin, A., Nusbaum, A. T., Whitney, P., Hinson, J. M., & McLaughlin, R. J. (2017). Blunted stress reactivity in chronic cannabis users. Psychopharmacology, 234(15), 2299–2309. https://doi.org/10.1007/s00213-017-4648-z
Gruber, S. A., Rogowska, J., & Yurgelun-Todd, D. A. (2009). Altered affective response in marijuana smokers: An FMRI study. Drug and Alcohol Dependence, 105(1–2), 139–153. https://doi.org/10.1016/j.drugalcdep.2009.06.019
Hyman, S. M., & Sinha, R. (2009). Stress-Related Factors in Cannabis Use and Misuse: Implications for Prevention and Treatment. Journal of Substance Abuse Treatment, 36(4), 400–413. https://doi.org/10.1016/j.jsat.2008.08.005
Micale, V., & Drago, F. (2018). Endocannabinoid system, stress and HPA axis. European Journal of Pharmacology, 834, 230–239. https://doi.org/10.1016/j.ejphar.2018.07.039
Orsolini, L., Chiappini, S., Volpe, U., De Berardis, D., Latini, R., Papanti, G. D., & Corkery, J. M. (2019). Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Medicina, 55(9). https://doi.org/10.3390/medicina55090525
Somaini, L., Manfredini, M., Amore, M., Zaimovic, A., Raggi, M. A., Leonardi, C., Gerra, M. L., Donnini, C., & Gerra, G. (2012). Psychobiological responses to unpleasant emotions in cannabis users. European Archives of Psychiatry and Clinical Neuroscience, 262(1), 47–57. https://doi.org/10.1007/s00406-011-0223-5
Turna, J., Patterson, B., & Van Ameringen, M. (2017). Is cannabis treatment for anxiety, mood, and related disorders ready for prime time? Depression and Anxiety, 34(11), 1006–1017. https://doi.org/10.1002/da.22664
